Latest news
Medline stock drops over 19% after FDA cites ma... - PluangPluang · Fri, 07 Aug 2026 22:54:51 GMTReplimune's stock jumps after FDA approves its first skin cancer drug Tudriqev - PluangPluang · Fri, 07 Aug 2026 15:51:23 GMTSVRA Stock Slips Post-Market After FDA Delays Decision On Pulmonary Therapy - StocktwitsStocktwits · Fri, 07 Aug 2026 09:13:51 GMTReplimune surges after FDA advisers back skin cancer drug - ReutersReuters · Fri, 31 Jul 2026 07:00:00 GMTOutlook Therapeutics Targets Multibillion Dollar Ophthalmology Market With New Drug After FDA Rejection - Yahoo FinanceYahoo Finance · Tue, 28 Jul 2026 07:00:00 GMT